A. Dutra-Clarke

发表

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Mads Thomassen, Nina Ditsch, Vijai Joseph, 2012, Breast Cancer Research.

Genetic Variation in DNA Repair Pathways and Risk of Non-Hodgkin's Lymphoma

C. Sander, B. Reva, Yevgeniy Antipin, 2014, PloS one.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers

V. Pankratz, F. Couch, B. Bonanni, 2012, Breast Cancer Research.

Susceptibility Loci Associated with Prostate Cancer Progression and Mortality

P. Scardino, J. Eastham, K. Offit, 2010, Clinical Cancer Research.

Susceptibility Loci Associated with Specific and Shared Subtypes of Lymphoid Malignancies

A. Viale, A. Zelenetz, K. Offit, 2013, PLoS genetics.

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry

M. Thun, R. Hayes, R. Hoover, 2012, Human Genetics.

Biomphalaria in South Carolina

A. Dutra-Clarke, R. Dillon, 1992 .

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.

F. Couch, B. Karlan, J. Benítez, 2011, Journal of the National Cancer Institute.

q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers

V. Pankratz, F. Couch, B. Bonanni, 2012 .

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

V. Pankratz, F. Couch, O. Olopade, 2010, Cancer research.

Common variants at 12 p 11 , 12 q 24 , 9 p 21 , 9 q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers

V. Pankratz, F. Couch, David Evans, 2017 .

Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women

C. Hudis, K. Offit, M. Gönen, 2011, Breast Cancer Research and Treatment.

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry

M. Thun, R. Hayes, R. Hoover, 2012, Human Genetics.